Leap Health’s Post

The effectiveness of a specialty drug relies on patients starting and maintaining treatment. That is where patient engagement strategies in integrated health system specialty pharmacies can support adherence and better outcomes, benefiting the broader health system. Learn more: https://bit.ly/3ZvXR4t

What opportunities exist for healthcare organizations looking to support patients who rely on specialty medications?   In this article, CarelonRx president Paul Marchetti explains our commitment to patient-centered care and how it drives affordability, accessibility, and collaboration within the healthcare system. https://lnkd.in/enXeE3k6 #HealthcareLeadership #PatientCare #SpecialtyMedications

Do the numbers $392 billion and $575 billion mean anything to you? These are, at minimum, the annual costs of absence from work and poor health in the workspace in the EU and the US! Read this article to understand what adherence to treatment has to do with them, and why it makes sense to start improving adherence levels already in clinical trials. And why the BEAMER project is important to all of us. https://lnkd.in/eBiDW_wY #patientadherence #patientengagement #patientrecruitment #clinicaltrials #clinicaloperations #healthcareinnovations #healthcareprofessionals #patientoutcomes #patientcentricity #clinicalcare #patientexperience #healthjourney #patientjourney #patientparticipation #regulators #healthinsurancepolicy

As healthcare providers, understanding the individual needs of our patients is essential to providing personalized care that leads to better health outcomes. The ARCHETYPES base approach for Market Access recognizes this critical aspect of patient care. By reflecting the evolving motivations, needs, fears, and care preferences of patients, we can provide the guidance that best serves their long-term health goals. Let's continue to prioritize patient-centered care and ensure that our patients receive the individualized attention they deserve. #patientcenteredcare #healthcareproviders #ARCHETYPES #MarketAccess https://lnkd.in/gMe7ECJV

Gene&Cell Therapy >> House passes sweeping healthcare price transparency reforms, reining in PBM practices: The House on Monday evening passed a wide-ranging bill that aims to make the healthcare industry more transparent, including amping up reporting requirements for insurers and banning spread pricing for pharmacy benefit managers. The 243-page bill, which was passed by a vote of 320-71 under suspension of the rules, was the culmination of work between the leaders of multiple committees and marks a major step forward in the bipartisan push to rein in PBMs. “This bipartisan legislation delivers on our commitment to lowering health care costs and providing increased transparency for patients — something 95 percent of Americans support,” House Energy and Commerce Committee chair Cathy McMorris Rodgers said. “It helps Americans save money on out-of-pocket expenses and seniors save millions on medicines through important Medicare payment reforms.” PBMs swiftly pushed back against the legislation, saying that it undermines their ability to establish the most cost-effective drug options for patients and will ultimately raise the price of medications. “Congress should acknowledge that the free market is working as evidenced by the concrete steps PBMs are taking to give employers more pharmacy benefit design choices and transparency — and not take Big Pharma’s bait and pass legislation that increases drug costs and Big Pharma profits,” the PBM lobby known as the Pharmaceutical Care Management Association said in a statement following the vote. Specifically, the bill requires PBMs to provide semi-annual reports to employer health plans with data on prescription drug spending. This includes the drugs’ acquisition costs, total out-of-pocket spending, its rationale for formulary placement, and aggregate rebate information. The bill also now ensures that any payment made by a PBM is passed through in its entirety to the pharmacy or provider that dispenses the drug and “is not retroactively denied or reduced,” the bill text says. The move, known as spread pricing, was included as part of a bill from Rep. Buddy Carter (R-GA). The package also includes legislation sponsored by Reps. Joe Courtney (D-CT) and Erin Houchin (R-IN) that requires PBMs and third party administrators to disclose compensation to plan fiduciaries. The legislation doubles down on an existing law that bans gag clauses, which prevent pharmacists from letting patients know about lower-cost drugs, confirming that the ban applies to all private health plans. Timothy L’Hommedieu, SVP of pharmacy at Atlas Health, told Endpoints News that the bill’s transparency measures around PBMs will require them to be up front about how much money they’re raking in. Timothy L’Hommedieu “You’re paying $100 and you don’t quite know whether the PBM is taking $20 of that… #lucidquest #genetherapy #celltherapy

Pharmacists could be great team members in value based care. With about 1/4th of patients having a pcp there is a clear opportunity to use pharmacists who are the most accessible hcps to improve care , access , experience and outcomes. However, this is a huge cultural shift and does come with some operational hurdles. I believe health technologies can eventually help address the latter which will further prove the value pharmacists bring in value based care #pharmacists #pharmacistsprovidecare #valuebasedcare #populationhealth #digitalhealth #vbc https://lnkd.in/eDHCBFGJ

Discover how Pharmacy Benefit Managers help drive Rx affordability, weight-loss drugs are driving up employers’ healthcare costs, new data is cause for concern over surprise medical bills, and more in this week’s newsletter. https://lnkd.in/eYJJfJ67

Many hospitals and health systems across the country are suffering soft or negative margins in the current financial environment and may not be aware of the massive opportunity to grow revenue through an improved specialty pharmacy strategy. Guardian Scripts works with employers, benefit advisors, and TPAs to match qualified patients to hospital pharmacy programs that not only deliver savings to health plans and enhance care for families but also generate revenue for hospitals seamlessly, without disrupting workflows or adding burdens. #SpecialtyPharmacy #HealthcareCosts #HealthcareSavings #EmployerBenefits #BenefitAdvisors #TPA #HealthcarePartnerships #HealthcareManagement #HealthcareIndustry #HealthcareLeadership #EmployeeBenefits #HealthcareSolutions

No one should have to skip the care – or the medications – they need because of the #costofhealthcare and yet, numerous studies show that even those with employer-sponsored benefits often do. That is why I am so proud of #RxBenefits' transparent, client-aligned #pharmacybenefitoptimization model that enables self-funded plans provide valuable, affordable #pharmacybenefits. Curious to see if we can help you? Learn more here: https://lnkd.in/etjmdVT9

Thank you, Fabrizio Gambino, for leading us in helping people on their journey to better health. With GLP-1 agonists, proper support from trained clinicians is vital for safe and effective weight loss. As Chief Clinical Officer of RPM Healthcare, I am proud to lead a team of passionate nurses dedicated to this mission. People on weight loss medications can lose muscle, and regain fat, making it crucial to promote sustainable weight loss methods. Our clinicians provide expertise and empathy, making a meaningful impact on patients' health journeys. We don't work with disease- we work with people!!!! If you are interested in learning about RPM - ask me a question. #RPM, #remotepatientmonitoring #weightloss